Edition:
United States

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

11.13USD
16 Feb 2018
Change (% chg)

$-0.10 (-0.89%)
Prev Close
$11.23
Open
$11.24
Day's High
$11.27
Day's Low
$11.03
Volume
43,556
Avg. Vol
59,722
52-wk High
$16.61
52-wk Low
$7.21

Latest Key Developments (Source: Significant Developments)

Sientra Announces Preliminary Unaudited Q4 Revenue
Monday, 8 Jan 2018 08:00am EST 

Jan 8 (Reuters) - Sientra Inc ::SIENTRA ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER 2017 REVENUE.SEES Q4 2017 REVENUE ABOUT $11.4 MILLION.Q4 REVENUE VIEW $11.8 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Sientra Inc Files For Mixed Shelf Of Upto $150 Million
Monday, 8 Jan 2018 06:20am EST 

Jan 8 (Reuters) - Sientra Inc ::SIENTRA INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING.  Full Article

Sientra posts qtrly loss of $0.74​ per share
Tuesday, 7 Nov 2017 04:01pm EST 

Nov 7 (Reuters) - Sientra Inc :Sientra reports third quarter 2017 financial results.Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016​.Qtrly ‍basic and diluted net loss per share attributable to common stockholders $0.74​.Net cash and cash equivalents as of September 30, 2017 were $37.6 million compared to $55.5 million at end of Q2 2017​.  Full Article

Sientra reports Q2 net loss per share attributable to stockholders $1.07​
Wednesday, 9 Aug 2017 04:01pm EDT 

Aug 10 (Reuters) - Sientra Inc -:Sientra® reports second quarter 2017 financial results.Q2 sales $8.2 million versus I/B/E/S view $7 million.Sientra Inc qtrly ‍basic and diluted net loss per share attributable to common stockholders $1.07​.  Full Article

Sientra, Silimed reach settlement of lawsuit and related arbitration
Tuesday, 1 Aug 2017 09:16am EDT 

Aug 1 (Reuters) - Sientra Inc ::Sientra says on June 27, co, Silimed Ind*A De Implantes Ltda reached settlement of lawsuit and related arbitration between them - SEC filing.Sientra says co agreed to pay Silimed lump sum of $9 million within 30-days of execution of settlement agreement, $1 million on or by July 1, 2018-SEC filing.Sientra Inc - company and Silimed have granted each other covenants not to sue with respect to certain specified conduct.Sientra Inc - parties executed settlement agreement on July 27, 2017.Sientra - should co enter international markets, has agreed to make royalty payments of $12.50 on net sales of certain breast implant specifications, up to $5 million.  Full Article

Sientra says settles lawsuit
Tuesday, 1 Aug 2017 08:30am EDT 

Aug 1 (Reuters) - Sientra Inc :Sientra announces settlement of lawsuit.Sientra - has entered into settlement agreement regarding mutual ip ownership and contract disputes with Silimed-Indústria De Implantes Ltda.  Full Article

Sientra Inc says amendment permits merger to be effected as a "short-form" merger‍​
Monday, 26 Jun 2017 06:25am EDT 

June 26 (Reuters) - Sientra Inc :Sientra Inc - co, Desert Acquisition Corp and Miramar Labs Inc. Entered into amendment no. 1 to agreement and plan of merger.Sientra Inc - the amendment permits the merger to be effected as a “short-form” merger‍​.Sientra Inc - amendment grants to co's unit right to buy from Miramar newly issued shares at a price equal to offer price- sec filing.  Full Article

Sientra to acquire Miramar labs for $20 million​
Monday, 12 Jun 2017 08:00am EDT 

June 12 (Reuters) - Sientra Inc :Sientra to acquire Miramar labs.‍sientra intends to secure a $50 million credit facility​.Keith Sullivan joins Sientra as strategic advisor.Sientra has agreed to acquire Miramar for an aggregate transaction value of $20 million​.Deal includes contractual rights for potential contingent payments of up to $14 million in cash upon achievement of certain milestones.Expect transaction to be meaningfully accretive to full year 2018 revenues.Transaction is not subject to a financing condition.Co has sufficient cash on hand to finance transaction.Co has also signed a term sheet with midcap financial services and silicon valley bank for a $50 million credit facility.Deal contemplates offer price of $0.3149/share plus right to get 1 or more contingent payments of up to about $0.7058/share on certain milestones ​.Subject to execution of definitive agreements, credit facility to be comprised of $40 million in term debt and a $10 million revolver.New credit facility is intended to replace Sientra's existing $20 million credit facility announced in march of 2017.  Full Article

Sientra reports Q1 loss per share of $0.61
Tuesday, 9 May 2017 04:01pm EDT 

May 9 (Reuters) - Sientra Inc :Sientra® reports first quarter 2017 financial results.Q1 sales $7.5 million versus $1.5 million.Q1 revenue view $6 million -- Thomson Reuters I/B/E/S.Sientra Inc qtrly loss per share $0.61.Q1 earnings per share view $-0.49, revenue view $6.0 million -- Thomson Reuters I/B/E/S.  Full Article

Sientra Q4 sales $6.5 million versus $1.5 million
Tuesday, 14 Mar 2017 04:01pm EDT 

Sientra Inc : Sientra reports fourth quarter and full year 2016 financial results . Q4 sales $6.5 million versus $1.5 million . Sientra inc- net loss for q4 of 2016 was $8.1 million, compared to $28.3 million for same period in 2015 . Sientra inc - announces $15 million line of credit with an additional $5 million credit facility . Sientra inc- net cash and cash equivalents were $67.2 million as of december 31, 2016 . Sientra inc - submitted final pma supplement to fda for new u.s. Manufacturing site .Sientra inc - "2017 is a pivotal year for us as we prepare to move into 2018 and beyond with our breast implant supply chain back and intact".  Full Article

BRIEF-Sientra Provides Update On FDA Review Of U.S. Manufacturing Facility

* SIENTRA® PROVIDES UPDATE ON FDA REVIEW OF U.S. MANUFACTURING FACILITY